HomePTHS • NYSEAMERICAN
add
Pelthos Therapeutics Inc
Previous close
$33.25
Day range
$32.78 - $33.30
Year range
$4.50 - $54.29
Market cap
101.24M USD
Avg Volume
13.27K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.72M | 55.08% |
Net income | -3.45M | -94.68% |
Net profit margin | — | — |
Earnings per share | -5.38 | -73.55% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.17K | -97.54% |
Total assets | 822.85K | -68.40% |
Total liabilities | 7.32M | 162.63% |
Total equity | -6.49M | — |
Shares outstanding | 3.04M | — |
Price to book | -3.45 | — |
Return on assets | -931.48% | — |
Return on capital | 274.60% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.45M | -94.68% |
Cash from operations | -447.14K | 84.85% |
Cash from investing | — | — |
Cash from financing | 375.00K | -76.37% |
Net change in cash | -72.14K | 94.72% |
Free cash flow | 827.61K | 135.32% |
About
Founded
2002
Website
Employees
4
